A detailed history of Hancock Whitney Corp transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Hancock Whitney Corp holds 48,693 shares of MEDP stock, worth $19.7 Million. This represents 0.68% of its overall portfolio holdings.

Number of Shares
48,693
Previous 44,861 8.54%
Holding current value
$19.7 Million
Previous $13.8 Million 43.11%
% of portfolio
0.68%
Previous 0.51%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 16, 2024

BUY
$284.87 - $413.31 $1.09 Million - $1.58 Million
3,832 Added 8.54%
48,693 $19.7 Million
Q4 2023

Feb 14, 2024

SELL
$227.52 - $312.68 $104,886 - $144,145
-461 Reduced 1.02%
44,861 $13.8 Million
Q3 2023

Nov 13, 2023

BUY
$233.98 - $281.67 $1.8 Million - $2.16 Million
7,673 Added 20.38%
45,322 $11 Million
Q2 2023

Nov 13, 2023

SELL
$187.26 - $240.17 $957,273 - $1.23 Million
-5,112 Reduced 11.95%
37,649 $9.04 Million
Q2 2023

Aug 10, 2023

SELL
$187.26 - $240.17 $957,273 - $1.23 Million
-5,112 Reduced 11.95%
37,649 $9.04 Million
Q1 2023

Nov 13, 2023

SELL
$174.31 - $239.52 $399,344 - $548,740
-2,291 Reduced 5.09%
42,761 $8.04 Million
Q1 2023

May 16, 2023

SELL
$174.31 - $239.52 $399,344 - $548,740
-2,291 Reduced 5.09%
42,761 $8.04 Million
Q4 2022

Nov 13, 2023

BUY
$153.06 - $226.57 $1.13 Million - $1.68 Million
7,403 Added 19.66%
45,052 $9.57 Million
Q4 2022

Feb 03, 2023

SELL
$153.06 - $226.57 $117,550 - $174,005
-768 Reduced 1.68%
45,052 $9.57 Million
Q3 2022

Oct 26, 2022

BUY
$145.13 - $182.49 $652,214 - $820,110
4,494 Added 10.87%
45,820 $7.2 Million
Q2 2022

Aug 08, 2022

SELL
$130.2 - $168.03 $432,524 - $558,195
-3,322 Reduced 7.44%
41,326 $6.19 Million
Q1 2022

May 12, 2022

BUY
$138.87 - $214.31 $4,304 - $6,643
31 Added 0.07%
44,648 $7.3 Million
Q4 2021

Jan 25, 2022

SELL
$182.74 - $227.9 $61,948 - $77,258
-339 Reduced 0.75%
44,617 $9.71 Million
Q3 2021

Nov 04, 2021

BUY
$170.18 - $198.21 $6.77 Million - $7.89 Million
39,804 Added 772.59%
44,956 $8.51 Million
Q2 2021

Aug 09, 2021

SELL
$158.62 - $194.3 $21,572 - $26,424
-136 Reduced 2.57%
5,152 $910,000
Q1 2021

May 14, 2021

SELL
$132.02 - $168.26 $372,296 - $474,493
-2,820 Reduced 34.78%
5,288 $867,000
Q4 2020

Feb 09, 2021

SELL
$109.38 - $149.19 $43,205 - $58,930
-395 Reduced 4.65%
8,108 $1.13 Million
Q3 2020

Nov 05, 2020

SELL
$92.95 - $130.61 $5,112 - $7,183
-55 Reduced 0.64%
8,503 $951,000
Q2 2020

Jul 30, 2020

SELL
$68.08 - $95.68 $167,749 - $235,755
-2,464 Reduced 22.36%
8,558 $796,000
Q1 2020

May 08, 2020

SELL
$61.71 - $101.95 $426,169 - $704,066
-6,906 Reduced 38.52%
11,022 $809,000
Q4 2019

Feb 06, 2020

SELL
$70.08 - $84.64 $112,758 - $136,185
-1,609 Reduced 8.24%
17,928 $1.51 Million
Q3 2019

Oct 29, 2019

SELL
$62.38 - $85.89 $120,580 - $166,025
-1,933 Reduced 9.0%
19,537 $1.64 Million
Q2 2019

Aug 29, 2019

BUY
$53.64 - $65.42 $1.15 Million - $1.4 Million
21,470 New
21,470 $1.41 Million

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $12.6B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Hancock Whitney Corp Portfolio

Follow Hancock Whitney Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hancock Whitney Corp, based on Form 13F filings with the SEC.

News

Stay updated on Hancock Whitney Corp with notifications on news.